ReviewCell2014
Individualized medicine from prewomb to tomb.
Review in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
124 citing papers in PubMed.
- Aortic Waveform Analysis to Individualize Treatment in Heart Failure.Circulation. Heart failure · 2017Trial
- CYP2D6 as an Emerging Endogenous Oxidative Stress Modulator in Cardiovascular Disease: Genetic, Pharmacological, and Redox Perspectives.Antioxidants (Basel, Switzerland) · 2026Review
- Graph statistics theory of individualized quantitative genetics under haplotype-resolved genome assembly.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome.NPJ genomic medicine · 2026Article
- Bibliometric analysis of atrial fibrillation and frailty research based on CiteSpace and VOSviewer.Medicine · 2025Article
- Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria.The EPMA journal · 2025Article
- Advances in Wearable Biosensors for Healthcare: Current Trends, Applications, and Future Perspectives.Biosensors · 2024Review
- Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology.Nature genetics · 2024Article
- Precision Medicine-Are We There Yet? A Narrative Review of Precision Medicine's Applicability in Primary Care.Journal of personalized medicine · 2024Review
- Artificial Intelligence and Precision Public Health: A Balancing Act of Scientific Accuracy, Social Responsibility, and Community Engagement.Portuguese journal of public health · 2024Article
- A Software Tool for Estimating Uncertainty of Bayesian Posterior Probability for Disease.Diagnostics (Basel, Switzerland) · 2024Article
- Heterogeneity in precision oncology.Cambridge prisms. Precision medicine · 2024Review
- Artificial intelligence in respiratory care.Frontiers in digital health · 2024Review
- Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework.Internet interventions · 2023Article
- A Bayesian Inference Based Computational Tool for Parametric and Nonparametric Medical Diagnosis.Diagnostics (Basel, Switzerland) · 2023Article
- Review
- Novel method for predicting nonvisible symptoms using machine learning in cancer palliative care.Scientific reports · 2023Article
- Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions.PLoS computational biology · 2023Article
- Ayurgenomics-based frameworks in precision and integrative medicine: Translational opportunities.Cambridge prisms. Precision medicine · 2023Review
- Clinical intuition in psychology through the prism of personalized psychiatry.Frontiers in psychology · 2023Article
64 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
That each of us is truly biologically unique, extending to even monozygotic, "identical" twins, is not fully appreciated. Now that it is possible to perform a comprehensive "omic" assessment of an individual, including one's DNA and RNA sequence and at least some characterization of one's proteome, metabolome, microbiome, autoantibodies, and epigenome, it has become abundantly clear that each of us has truly one-of-a-kind biological content. Well beyond the allure of the matchless fingerprint or snowflake concept, these singular, individual data and information set up a remarkable and unprecedented opportunity to improve medical treatment and develop preventive strategies to preserve health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.